β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection
Authors
Keywords
-
Journal
GENE THERAPY
Volume 22, Issue 5, Pages 430-438
Publisher
Springer Nature
Online
2015-03-19
DOI
10.1038/gt.2015.18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beta cell regeneration after single-round immunological destruction in a mouse model
- (2014) Jason M. Tonne et al. DIABETOLOGIA
- M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7
- (2014) Xiangwei Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Concise Review: Pluripotent Stem Cell-Based Regenerative Applications for Failingβ-Cell Function
- (2014) Sara J. Holditch et al. Stem Cells Translational Medicine
- Death and Dysfunction of Transplanted -Cells: Lessons Learned From Type 2 Diabetes?
- (2013) K. J. Potter et al. DIABETES
- Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
- (2013) Tihamer Orban et al. DIABETES CARE
- Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced -cell damage and pancreatic Glp-1 gene therapy
- (2013) J. M. Tonne et al. Disease Models & Mechanisms
- Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
- (2012) Teodora P. Staeva et al. DIABETES
- Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010
- (2012) F. B. Barton et al. DIABETES CARE
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
- (2011) Tom L. Van Belle et al. PHYSIOLOGICAL REVIEWS
- Unique Cellular and Mitochondrial Defects Mediate FK506-Induced Islet β-Cell Dysfunction
- (2011) Nassir Rostambeigi et al. TRANSPLANTATION
- The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time
- (2010) Antonios Chatzigeorgiou et al. ANNALS OF MEDICINE
- Genetics, pathogenesis and clinical interventions in type 1 diabetes
- (2010) Jeffrey A. Bluestone et al. NATURE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
- (2009) Brian T Fife et al. NATURE IMMUNOLOGY
- Prolonged Insulin Independence After Islet Allotransplants in Recipients with Type 1 Diabetes
- (2008) M. D. Bellin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr−/−-dependent allergy mouse model
- (2008) C Mueller et al. GENE THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now